Redona Therapeutics

0 followers


Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

Industries

Employees

Links

Org chart

Kazumi Shiosaki
President & CEO

Kazumi Shiosaki

Collapse
Shomir Ghosh
Chief Scientific Officer
Edward Darr
VP, Finance & Operations